GOP Bioterror Bill Includes Vaccine Liability Reform, FDA "Rapid-Action" Team
This article was originally published in The Pink Sheet Daily
Executive Summary
Senate leadership biodefense bill includes several provisions that could have broad implications for the vaccine market. S 3 would grant "fast track" status to all "second generation" vaccines, and includes an FDA preemption clause.